Ventas Inc
NYSE:VTR

Watchlist Manager
Ventas Inc Logo
Ventas Inc
NYSE:VTR
Watchlist
Price: 64.03 USD -0.42% Market Closed
Market Cap: 26.9B USD
Have any thoughts about
Ventas Inc?
Write Note

Ventas Inc
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ventas Inc
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
Ventas Inc
NYSE:VTR
Note Receivable
$371.8m
CAGR 3-Years
-19%
CAGR 5-Years
-21%
CAGR 10-Years
-5%
Welltower Inc
NYSE:WELL
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Omega Healthcare Investors Inc
NYSE:OHI
Note Receivable
$1.7B
CAGR 3-Years
24%
CAGR 5-Years
16%
CAGR 10-Years
10%
Healthcare Realty Trust Inc
NYSE:HR
Note Receivable
$173.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
20%
Physicians Realty Trust
NYSE:DOC
Note Receivable
$677.6m
CAGR 3-Years
14%
CAGR 5-Years
22%
CAGR 10-Years
-22%
C
CareTrust REIT Inc
NYSE:CTRE
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Ventas Inc
Glance View

Market Cap
26.8B USD
Industry
Real Estate

Ventas Inc. is a leading real estate investment trust (REIT) specializing in the healthcare sector, with a portfolio that spans various facets of senior living, research facilities, and medical office buildings. Founded in 1998, Ventas has strategically positioned itself to capitalize on the growing demand for healthcare services driven by an aging population and increasing healthcare expenditures. The company's diverse portfolio, which includes properties leased to skilled nursing facilities, independent living communities, and life science organizations, allows it to generate steady rental income while spreading risk across multiple healthcare segments. This unique positioning not only delivers consistent cash flow but also aligns with long-term demographic trends, making Ventas a compelling choice for investors looking for stability in an evolving market. As Ventas continues to expand its footprint, it remains committed to innovation and sustainability, investing in properties that are equipped to meet the needs of a growing population while also contributing positively to the environment. The company's disciplined acquisition strategy, combined with a focus on maintaining strong relationships with high-quality operators, underscores its commitment to delivering value to shareholders. In addition to its impressive financial track record, Ventas has a dividend policy that reflects its dedication to returning capital to investors, cementing its reputation as a reliable investment in the healthcare REIT space. For those looking to invest in a company that offers both growth potential and income generation, Ventas presents a prudent opportunity rooted in the fundamental demand for healthcare services.

VTR Intrinsic Value
51.47 USD
Overvaluation 20%
Intrinsic Value
Price

See Also

What is Ventas Inc's Note Receivable?
Note Receivable
371.8m USD

Based on the financial report for Sep 30, 2024, Ventas Inc's Note Receivable amounts to 371.8m USD.

What is Ventas Inc's Note Receivable growth rate?
Note Receivable CAGR 10Y
-5%

Over the last year, the Note Receivable growth was 52%. The average annual Note Receivable growth rates for Ventas Inc have been -19% over the past three years , -21% over the past five years , and -5% over the past ten years .

Back to Top